A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationale
一项评估sacituzumab govitecan联合或不联合atezolizumab治疗罕见泌尿生殖系统肿瘤的II期研究(SMART)——设计和原理
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2516901
Kydd, Andre R; Chandran, Elias; Simon, Nicholas I; Atiq, Saad; Ley, Lisa; Wang, Tzu-Fang; Cordes, Lisa; Patel, Ruchi; Smith, Elizabeth; Boudjadi, Salah; Niglio, Scot A; Yousefi-Rad, Abbas; Weng, Sally; Stukes, Ian; Banday, A Rouf; Akbulut, Dilara; Gurram, Sandeep; Redd, Bernadette; Steinberg, Seth; Choo-Wosoba, Hyoyoung; Apolo, Andrea B